Category: Biologics
Global Biologics
-
Biologic Therapeutic Drugs: Technologies and Global Markets
... analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2028, as well as key market players. This report details market shares for ... Read More
-
Biologics Contract Development Market Report: Trends, Forecast and Competitive Analysis to 2030
... disorder, cardiovascular disorder, and hematological disorder markets. The global biologics contract development market is expected to reach an estimated $40.9 billion by 2030 with a CAGR of 11.5% from 2024 to 2030. The major drivers ... Read More
-
Rare Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... North America Leads with a Dominant Market Share The global rare disease treatment market is on an upward trajectory, with the genetic diseases segment expected to maintain its dominance in the coming years, according to ... Read More
-
Global Cell Culture Media Market Size Study & Forecast, by Type (Serum-free Media, Classical Media & Salts, Stem Cell Culture Media, Specialty Media, Chemically defined Media, Other Cell Culture Media), by Application (Biopharmaceutical Production, Diagnostics, Drug Screening & Development, Other Applications), by End user, and Regional Analysis, 2023-2030
... Drug Screening & Development, Other Applications), by End user, and Regional Analysis, 2023-2030 Global Cell Culture Media Market is valued at approximately USD 5.34 billion in 2022 and is anticipated to grow with a healthy ... Read More
-
Wound Care Biologics Global Market Report 2024
... Wound ClinicsCovering: Integra Lifesciences Corporation; Organogenesis Inc.; Smith and Nephew plc; Wright Medical Group NV; MiMedx Group Inc. Wound Care Biologics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Biopharmaceuticals Contract Manufacturing Global Market Report 2024
... Operations; Analytical And QC studies; Packaging4) By Application: Clinical; CommercialCovering: Boehringer Ingelheim GmbH; Lonza Group Ltd.; Inno Biologics Sdn Bhd; Rentschler Biopharma SE; Samsung Biologics Co. Ltd. Biopharmaceuticals Contract Manufacturing Global Market Report 2024 from ... Read More
-
Biologics Testing Global Market Report 2024
... By Application: Vaccine Development And Manufacturing; Monoclonal Antibodies Development And Manufacturing; Cellular And Gene Therapy Products Development And Manufacturing; Blood And Blood Products Development And ManufacturingCovering: Charles River Laboratories Inc.; Thermo Fisher Scientific Inc.; Merck ... Read More
-
Biopharmaceutical Bioseparation Systems Market by Type (Cell Disruption Technology, Centrifuges Technology, Chromatography Technique), End-user (Biopharmaceutical Companies, Research Institutes) - Global Forecast 2024-2030
... 2023 and expected to reach USD 16.48 billion in 2024, at a CAGR 9.49% to reach USD 28.49 billion by 2030. Global Biopharmaceutical Bioseparation Systems Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type (Consumables, Instruments, Services), Type (Compendial Testing, Custom Testing, Laboratory Testing), Application - Global Forecast 2024-2030
... million in 2023 and expected to reach USD 621.39 million in 2024, at a CAGR 11.71% to reach USD 1,213.54 million by 2030. Global Biopharmaceuticals Manufacturing Consumables Testing Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Biopharmaceutical CMO & CRO Market by Source (Mammalian, Non-Mammalian), Service Type (Contract Manufacturing, Contract Research), Product, Scale of Operation, Therapeutic Applications - Global Forecast 2024-2030
... USD 81.32 billion in 2023 and expected to reach USD 95.65 billion in 2024, at a CAGR 18.10% to reach USD 260.65 billion by 2030. Global Biopharmaceutical CMO & CRO Market FPNV Positioning Matrix The ... Read More
-
Biopharmaceutical Fermentation System Market by Product (Downstream Process Product, Upstream Process Product), Application (Antibiotics, Monoclonal Antibodies, Probiotics), End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 16.86 billion in 2024, at a CAGR 7.82% to reach USD 26.52 billion by 2030. Global Biopharmaceutical Fermentation System Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Anti-Inflammatory Therapeutics Market by Drug Class (Anti-inflammatory Biologics, Corticosteroids, Non-steroidal Anti-inflammatory Drugs (NSAIDs)), Indication (Anti-inflammatory Bowel Disease, Arthritis, Multiple Sclerosis), Application - Global Forecast
... billion in 2023 and expected to reach USD 103.85 billion in 2024, at a CAGR 4.93% to reach USD 142.21 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Drug Discovery Technologies Market by Technology (Bioanalytical Instruments, Biochips, Bioinformatics), Drug Type (Biologic Drugs, Small-molecule Drugs), End User - Global Forecast 2024-2030
... 2023 and expected to reach USD 71.32 billion in 2024, at a CAGR 10.64% to reach USD 131.08 billion by 2030. Drug discovery consists of new medications being discovered by using a vast array of ... Read More
-
Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
... USD 24.01 billion in 2023 and expected to reach USD 28.82 billion in 2024, at a CAGR 20.13% to reach USD 86.73 billion by 2030. Global Regenerative Medicine Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Pompe Disease Market by Therapy Type (Enzyme, Substrate), Molecule Type (Biologics, Small Molecules), Dosage Form, Route of Administration - Global Forecast 2024-2030
... and expected to reach USD 1.59 billion in 2024, at a CAGR 5.61% to reach USD 2.21 billion by 2030. Global Pompe Disease Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Cell Culture Market by Product (Consumables, Equipment), Application (Biopharmaceutical Production, Cell Banking, Diagnostics) - Global Forecast 2024-2030
... 33.05 billion in 2024, at a CAGR 15.36% to reach USD 77.98 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cell Culture Market. It offers a comprehensive assessment ... Read More
-
Systemic Lupus Erythematosus Market by Drug Type (Antimalarial Drugs, B-Cell Modulators, Biologics), Mode of Delivery (Intravenous, Oral, Subcutaneous) - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.24 billion in 2024, at a CAGR 10.54% to reach USD 4.12 billion by 2030. Global Systemic Lupus Erythematosus Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Ulcerative Colitis Market by Drug (Anti-Inflammatory Drugs, Anti-TNF Biologics, Calcineurin Inhibitors), Disease (Fulminant Colitis, Left-Sided Colitis, Pancolitis or Universal Colitis), Route of Administration - Global Forecast 2024-2030
... USD 7.45 billion in 2023 and expected to reach USD 8.14 billion in 2024, at a CAGR 9.41% to reach USD 13.99 billion by 2030. Global Ulcerative Colitis Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Spine Biologics Market by Product (Bone Graft Substitutes, Cell-Base Matrix, Spinal Allografts), Application (Non-Fusion, Spinal Fusion), End-user - Global Forecast 2024-2030
... expected to reach USD 3.15 billion in 2024, at a CAGR 5.24% to reach USD 4.30 billion by 2030. Global Spine Biologics MarketSpine biologics refer to a category of medical products and treatments that utilize ... Read More
-
Biologics Market by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies), Indication (Autoimmune Diseases, Cancer, Infectious Diseases), End-user - Global Forecast 2024-2030
... and expected to reach USD 302.68 billion in 2024, at a CAGR 5.39% to reach USD 415.18 billion by 2030. Global Biologics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Biologics Contract Development Market by Source (Mammalian, Microbial), Type (Molecular Therapy, Monoclonal Antibodies, Recombinant Proteins), Disease Indication, Phase, Service Type, End-User - Global Forecast 2024-2030
... 6.54 billion in 2023 and expected to reach USD 7.30 billion in 2024, at a CAGR 11.79% to reach USD 14.28 billion by 2030. Global Biologics Contract Development Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Microcarriers Market by Product (Consumables, Equipment), Application (Biologics Manufacturing, Cell Therapy, Vaccine Manufacturing), End User - Global Forecast 2024-2030
... USD 2.37 billion in 2024, at a CAGR 9.99% to reach USD 4.22 billion by 2030. Global Microcarriers MarketMicrocarriers are small spherical beads made from materials such as dextran, polystyrene, gelatin, or glass that provide ... Read More
-
Biologics Contract Development & Manufacturing Organization Market by Type (Mammalian, Non-mammalian), Product Type (Biologics, Biosimilars), Disease Indication, Service Type, End-User - Global Forecast 2024-2030
... at USD 9.88 billion in 2023 and expected to reach USD 10.59 billion in 2024, at a CAGR 7.44% to reach USD 16.35 billion by 2030. Global Biologics Contract Development & Manufacturing Organization MarketBiologics contract ... Read More
-
Life Sciences BPO Market by Services (Contract Sales & Marketing Outsourcing, Medical Devices Outsourcing, Pharmaceutical Outsourcing), Application (Medical Devices, Pharmaceutical & Biopharmaceuticals) - Global Forecast 2024-2030
... USD 387.64 billion in 2023 and expected to reach USD 423.92 billion in 2024, at a CAGR 9.49% to reach USD 731.43 billion by 2030. Global Life Sciences BPO Market FPNV Positioning Matrix The FPNV ... Read More
-
Biological Safety Cabinet Market by Type (Class I, Class II, Class III), End User (Academic & Research Organizations, Diagnostics & Testing Laboratories, Pharmaceutical & Biopharmaceutical Companies) - Global Forecast 2024-2030
... size was estimated at USD 456.46 million in 2023 and expected to reach USD 494.74 million in 2024, at a CAGR 8.47% to reach USD 806.93 million by 2030. Global Biological Safety Cabinet Market FPNV ... Read More
Research Assistance
